Pharma Industry News Boehringer Ingelheim’s Jascayd approved by MHRA for idiopathic pulmonary fibrosis 2 hours agoAdd Commentby David Miller945 Views This is the first treatment breakthrough in pulmonary fibrosis in over a decade Source: PMLiVE